Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


GSK/HGS' Benlysta Gets Advisory Committee Date, But Panel May Have Acting Chair

This article was originally published in The Pink Sheet Daily

Executive Summary

The chair of FDA's Arthritis Drugs Advisory Committee, Kathleen O'Neil, University of Oklahoma, is co-investigator in a trial of another drug for systemic lupus erythematosus.

Related Content

Late-Stage Lupus Therapies Glow In Halo Of Benlysta Spotlight
FDA Guidances On Lupus Drug Development Call For Superiority Trials
March 2010 Approvals





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts